Pots 15-3530. Quote #an_105695 for c. Mejias-aponte.

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201500078C
Awardee
Awarding agency
Obligated
$319,885

Award facts

Contract value 100% obligated
$319,885.49 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $319,885

About this award

This federal contract award, identified as HHSN271201500078C, was made by the National Institute on Drug Abuse, a civilian agency, to Lavision Biotec GMBH, a for-profit organization and manufacturer of goods. The contract is a definitive, firm fixed-price contract with a ceiling value of $319,885.49 and an ultimate completion date of February 10, 2016. The contract was awarded on August 5, 2015 and does not have a set-aside designation. The contract appears to be for POTS 15-3530, as described in the government description, but additional details about the requested products or services are not provided.

Quick answers

Who was awarded contract HHSN271201500078C?

HHSN271201500078C was awarded to Lavision Biotec GMBH by National Institute on Drug Abuse (National Institutes of Health) on August 5, 2015.

How much is contract HHSN271201500078C worth?

The government has obligated $319,885 on HHSN271201500078C.

Was contract HHSN271201500078C competed?

The extent of competition for HHSN271201500078C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award